Y. Furuya

发表

Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis

N. Udagawa, T. Ninomiya, Midori Nakamura, 2017, PloS one.

The local administration of TNF-α and RANKL antagonist peptide promotes BMP-2-induced bone formation

K. Aoki, K. Ohya, M. Mamun, 2013 .

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

J. Penninger, K. Aoki, K. Ohya, 2013, The Journal of Biological Chemistry.

Osteoclast differentiation by RANKL and OPG signaling pathways

N. Udagawa, T. Yamashita, Midori Nakamura, 2020, Journal of Bone and Mineral Metabolism.

The W9 peptide directly stimulates osteoblast differentiation via RANKL signaling

J. Penninger, T. Mizoguchi, N. Udagawa, 2017 .

PARTICIPATION OF CONTRASTING CHANGES IN IL-10 AND IL-12 production-dates printpubdate="05/03/02" IN THE REDUCTION OF TH1-PREDOMINANCE BY HACHIMI-JIO-GAN IN AUTOIMMUNE MRL/MP-lpr/lpr MICE

K. Nomoto, T. Kawakita, Y. Furuya, 2002 .

Suppressive effect of a traditional Japanese medicine, Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan), on the hyperresponsiveness to IL-18 in autoimmune MRL/MPJ-lpr/lpr mice.

K. Nomoto, T. Kawakita, Y. Furuya, 2003, International immunopharmacology.

Induction of chondrogenesis with a RANKL-binding peptide, WP9QY, in vitro and in vivo in a rabbit model

Hiroaki Nakamura, S. Wakitani, H. Yasuda, 2022, Biochemical and Biophysical Research Communications.

Increased bone mass in mice after single injection of anti-receptor activator of nuclear factor-kappaB ligand-neutralizing antibody: evidence for bone anabolic effect of parathyroid hormone in mice with few osteoclasts.

Sakae Tanaka, N. Udagawa, T. Ninomiya, 2011, The Journal of biological chemistry.

Increased Bone Mass in Mice after Single Injection of Anti-receptor Activator of Nuclear Factor-κB Ligand-neutralizing Antibody

Sakae Tanaka, N. Udagawa, T. Ninomiya, 2011, The Journal of Biological Chemistry.

Immunomodulating effect of a traditional Japanese medicine, hachimi-jio-gan (ba-wei-di-huang-wan), on Th1 predominance in autoimmune MRL/MP-lpr/lpr mice.

K. Nomoto, T. Kawakita, Y. Furuya, 2001, International immunopharmacology.

Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector

J. Miyazaki, H. Yasuda, Y. Furuya, 2011, Journal of Bone and Mineral Metabolism.